 Matthew Kelly
Concepts (166)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nasopharynx | 8 | 2025 | 34 | 3.080 |
Why?
| | Pneumococcal Infections | 4 | 2022 | 11 | 2.870 |
Why?
| | Pneumonia | 6 | 2021 | 125 | 2.700 |
Why?
| | Respiratory Tract Infections | 5 | 2025 | 87 | 2.480 |
Why?
| | Bacteria | 8 | 2025 | 228 | 2.080 |
Why?
| | Hematopoietic Stem Cell Transplantation | 4 | 2024 | 603 | 1.910 |
Why?
| | Botswana | 14 | 2024 | 29 | 1.800 |
Why?
| | Antibodies, Neutralizing | 4 | 2024 | 78 | 1.740 |
Why?
| | Antibodies, Viral | 4 | 2024 | 109 | 1.740 |
Why?
| | HIV Infections | 5 | 2022 | 389 | 1.710 |
Why?
| | Infant | 20 | 2025 | 3733 | 1.550 |
Why?
| | Streptococcus pneumoniae | 4 | 2025 | 25 | 1.330 |
Why?
| | Respiratory Syncytial Virus Infections | 3 | 2022 | 42 | 1.270 |
Why?
| | Child | 19 | 2025 | 7248 | 1.270 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2025 | 118 | 1.250 |
Why?
| | Pregnancy Complications, Infectious | 2 | 2020 | 81 | 1.180 |
Why?
| | Pneumococcal Vaccines | 3 | 2022 | 13 | 1.140 |
Why?
| | Prospective Studies | 11 | 2025 | 2481 | 1.110 |
Why?
| | Bacterial Typing Techniques | 2 | 2024 | 36 | 1.090 |
Why?
| | Respiratory Syncytial Virus, Human | 3 | 2022 | 15 | 1.040 |
Why?
| | Phylogeny | 2 | 2024 | 231 | 1.020 |
Why?
| | Communicable Diseases | 2 | 2024 | 55 | 1.000 |
Why?
| | Base Composition | 1 | 2024 | 23 | 0.910 |
Why?
| | Humans | 38 | 2025 | 52483 | 0.910 |
Why?
| | Nucleic Acid Hybridization | 1 | 2024 | 56 | 0.910 |
Why?
| | Carnobacteriaceae | 1 | 2024 | 1 | 0.880 |
Why?
| | Gram-Positive Cocci | 1 | 2024 | 3 | 0.880 |
Why?
| | DNA, Bacterial | 1 | 2024 | 176 | 0.870 |
Why?
| | Fatty Acids | 1 | 2024 | 149 | 0.860 |
Why?
| | Sequence Analysis, DNA | 1 | 2024 | 229 | 0.840 |
Why?
| | Anti-Infective Agents | 2 | 2023 | 107 | 0.800 |
Why?
| | Infant, Newborn | 9 | 2025 | 2867 | 0.800 |
Why?
| | Clostridium Infections | 1 | 2023 | 55 | 0.790 |
Why?
| | Serotyping | 1 | 2022 | 11 | 0.770 |
Why?
| | Haemophilus influenzae type b | 1 | 2021 | 1 | 0.740 |
Why?
| | Transplantation, Homologous | 2 | 2020 | 150 | 0.740 |
Why?
| | Haemophilus Vaccines | 1 | 2021 | 3 | 0.740 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2021 | 11 | 0.740 |
Why?
| | Bacterial Infections | 2 | 2019 | 101 | 0.720 |
Why?
| | Female | 21 | 2025 | 28171 | 0.680 |
Why?
| | Maternal-Fetal Exchange | 1 | 2020 | 49 | 0.670 |
Why?
| | Feces | 2 | 2020 | 153 | 0.670 |
Why?
| | Culture Media | 1 | 2020 | 98 | 0.660 |
Why?
| | Specimen Handling | 1 | 2020 | 56 | 0.660 |
Why?
| | Radiography, Thoracic | 2 | 2020 | 67 | 0.660 |
Why?
| | Cryopreservation | 1 | 2020 | 41 | 0.650 |
Why?
| | Male | 20 | 2025 | 26761 | 0.650 |
Why?
| | Graft vs Host Disease | 1 | 2020 | 87 | 0.650 |
Why?
| | Child, Preschool | 8 | 2025 | 4076 | 0.650 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 178 | 0.640 |
Why?
| | Drug Resistance, Bacterial | 1 | 2019 | 82 | 0.620 |
Why?
| | Cord Blood Stem Cell Transplantation | 1 | 2018 | 9 | 0.620 |
Why?
| | Carrier State | 1 | 2018 | 10 | 0.610 |
Why?
| | Autopsy | 1 | 2018 | 48 | 0.590 |
Why?
| | Intestinal Mucosa | 1 | 2019 | 224 | 0.580 |
Why?
| | Asthma | 1 | 2022 | 316 | 0.570 |
Why?
| | Transplantation Conditioning | 1 | 2018 | 93 | 0.560 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2019 | 197 | 0.530 |
Why?
| | Cohort Studies | 5 | 2024 | 1542 | 0.500 |
Why?
| | Adolescent | 7 | 2025 | 6739 | 0.500 |
Why?
| | Anti-Bacterial Agents | 4 | 2024 | 807 | 0.480 |
Why?
| | HIV Seropositivity | 1 | 2014 | 28 | 0.460 |
Why?
| | Corynebacterium | 2 | 2025 | 3 | 0.430 |
Why?
| | Vaccines, Conjugate | 2 | 2022 | 9 | 0.380 |
Why?
| | Gastrointestinal Tract | 2 | 2023 | 108 | 0.350 |
Why?
| | Transcriptome | 2 | 2025 | 370 | 0.340 |
Why?
| | Probiotics | 2 | 2022 | 24 | 0.330 |
Why?
| | Young Adult | 3 | 2025 | 4329 | 0.300 |
Why?
| | Retrospective Studies | 4 | 2022 | 6607 | 0.280 |
Why?
| | Breast Feeding | 2 | 2020 | 197 | 0.280 |
Why?
| | Adult | 5 | 2025 | 14161 | 0.270 |
Why?
| | Treatment Failure | 2 | 2019 | 122 | 0.270 |
Why?
| | Haemophilus influenzae | 1 | 2025 | 17 | 0.240 |
Why?
| | Adaptive Immunity | 1 | 2025 | 34 | 0.230 |
Why?
| | Tertiary Care Centers | 2 | 2016 | 85 | 0.230 |
Why?
| | Genome, Bacterial | 1 | 2024 | 58 | 0.220 |
Why?
| | Fluoroquinolones | 1 | 2024 | 25 | 0.220 |
Why?
| | Immune System | 1 | 2024 | 42 | 0.220 |
Why?
| | Hospitalization | 2 | 2021 | 736 | 0.220 |
Why?
| | Immunity, Innate | 1 | 2025 | 117 | 0.220 |
Why?
| | Disease Susceptibility | 1 | 2024 | 95 | 0.220 |
Why?
| | Case-Control Studies | 2 | 2018 | 1201 | 0.210 |
Why?
| | Vaccines | 1 | 2024 | 51 | 0.210 |
Why?
| | Pneumonia, Bacterial | 2 | 2021 | 32 | 0.210 |
Why?
| | Respiratory Syncytial Virus Vaccines | 1 | 2022 | 3 | 0.200 |
Why?
| | Antibodies, Bacterial | 1 | 2022 | 30 | 0.200 |
Why?
| | Pregnancy | 2 | 2020 | 2680 | 0.190 |
Why?
| | Gastroenteritis | 1 | 2022 | 19 | 0.190 |
Why?
| | Immunoglobulin G | 1 | 2022 | 195 | 0.190 |
Why?
| | Age Factors | 1 | 2025 | 1132 | 0.180 |
Why?
| | Viral Load | 1 | 2021 | 82 | 0.180 |
Why?
| | Diarrhea | 2 | 2022 | 95 | 0.180 |
Why?
| | Population Surveillance | 1 | 2022 | 165 | 0.180 |
Why?
| | Kinetics | 1 | 2022 | 626 | 0.170 |
Why?
| | Immunity, Maternally-Acquired | 1 | 2020 | 4 | 0.170 |
Why?
| | Anaerobiosis | 1 | 2020 | 20 | 0.170 |
Why?
| | Leukocytes, Mononuclear | 1 | 2021 | 123 | 0.170 |
Why?
| | Respiratory Syncytial Viruses | 2 | 2022 | 15 | 0.170 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 100 | 0.170 |
Why?
| | Clinical Competence | 2 | 2020 | 406 | 0.170 |
Why?
| | Viruses | 1 | 2020 | 25 | 0.160 |
Why?
| | Diagnostic Errors | 1 | 2020 | 68 | 0.160 |
Why?
| | Whooping Cough | 1 | 2019 | 11 | 0.160 |
Why?
| | Aged | 2 | 2025 | 10121 | 0.160 |
Why?
| | Medical Laboratory Personnel | 1 | 2019 | 5 | 0.160 |
Why?
| | Linear Models | 1 | 2020 | 287 | 0.160 |
Why?
| | Infant Nutrition Disorders | 1 | 2019 | 2 | 0.160 |
Why?
| | Multivariate Analysis | 1 | 2020 | 591 | 0.150 |
Why?
| | Respiratory Therapy | 1 | 2019 | 36 | 0.150 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2020 | 182 | 0.150 |
Why?
| | Anti-HIV Agents | 1 | 2019 | 46 | 0.150 |
Why?
| | History, 21st Century | 1 | 2018 | 59 | 0.150 |
Why?
| | Program Development | 1 | 2019 | 165 | 0.150 |
Why?
| | Infant, Low Birth Weight | 1 | 2019 | 79 | 0.150 |
Why?
| | Radiology | 1 | 2020 | 134 | 0.150 |
Why?
| | History, 20th Century | 1 | 2018 | 96 | 0.150 |
Why?
| | Polymerase Chain Reaction | 1 | 2018 | 461 | 0.140 |
Why?
| | Genetic Variation | 1 | 2018 | 230 | 0.140 |
Why?
| | Aged, 80 and over | 1 | 2025 | 3392 | 0.140 |
Why?
| | Coronavirus Infections | 1 | 2020 | 188 | 0.140 |
Why?
| | Hospital Mortality | 1 | 2019 | 435 | 0.130 |
Why?
| | Biomedical Research | 1 | 2019 | 256 | 0.130 |
Why?
| | Survival Rate | 1 | 2018 | 945 | 0.130 |
Why?
| | Pandemics | 1 | 2020 | 585 | 0.120 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1105 | 0.120 |
Why?
| | Length of Stay | 1 | 2019 | 663 | 0.120 |
Why?
| | Coinfection | 1 | 2016 | 47 | 0.120 |
Why?
| | Enterovirus | 1 | 2015 | 8 | 0.120 |
Why?
| | Metapneumovirus | 1 | 2015 | 6 | 0.120 |
Why?
| | Multiplex Polymerase Chain Reaction | 1 | 2015 | 13 | 0.120 |
Why?
| | Rhinovirus | 1 | 2015 | 24 | 0.120 |
Why?
| | Seasons | 1 | 2015 | 92 | 0.120 |
Why?
| | Cross-Sectional Studies | 1 | 2020 | 1678 | 0.120 |
Why?
| | RNA, Viral | 1 | 2015 | 127 | 0.110 |
Why?
| | Risk | 1 | 2015 | 316 | 0.110 |
Why?
| | Odds Ratio | 1 | 2016 | 558 | 0.110 |
Why?
| | Risk Factors | 2 | 2020 | 3889 | 0.110 |
Why?
| | Prognosis | 1 | 2019 | 2099 | 0.110 |
Why?
| | Referral and Consultation | 1 | 2015 | 292 | 0.100 |
Why?
| | Time Factors | 1 | 2018 | 2968 | 0.100 |
Why?
| | Treatment Outcome | 2 | 2019 | 5422 | 0.090 |
Why?
| | United States | 1 | 2022 | 5192 | 0.090 |
Why?
| | Middle Aged | 1 | 2025 | 13028 | 0.080 |
Why?
| | Animals | 1 | 2024 | 13505 | 0.080 |
Why?
| | Vaccines, Attenuated | 1 | 2022 | 11 | 0.050 |
Why?
| | Cough | 1 | 2022 | 55 | 0.050 |
Why?
| | Asymptomatic Diseases | 1 | 2021 | 38 | 0.050 |
Why?
| | Lysogeny | 1 | 2020 | 2 | 0.040 |
Why?
| | Prophages | 1 | 2020 | 2 | 0.040 |
Why?
| | Bacteriolysis | 1 | 2020 | 3 | 0.040 |
Why?
| | Meconium | 1 | 2020 | 6 | 0.040 |
Why?
| | Bacteriophages | 1 | 2020 | 9 | 0.040 |
Why?
| | Inservice Training | 1 | 2020 | 31 | 0.040 |
Why?
| | Influenza, Human | 1 | 2021 | 93 | 0.040 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 144 | 0.040 |
Why?
| | Comorbidity | 1 | 2020 | 625 | 0.040 |
Why?
| | Career Choice | 1 | 2019 | 116 | 0.040 |
Why?
| | Quality Improvement | 1 | 2020 | 226 | 0.040 |
Why?
| | Cytokines | 1 | 2021 | 623 | 0.040 |
Why?
| | Severity of Illness Index | 1 | 2020 | 1026 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2020 | 1046 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2020 | 1229 | 0.030 |
Why?
| | Prevalence | 1 | 2019 | 1006 | 0.030 |
Why?
| | Pilot Projects | 1 | 2017 | 721 | 0.030 |
Why?
| | Internship and Residency | 1 | 2019 | 448 | 0.030 |
Why?
| | Signal Transduction | 1 | 2021 | 1671 | 0.030 |
Why?
|
|
Kelly's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|